SFRP2 was identified as a regulator of the TME through its impact on Wnt signaling and tumor angiogenesis [41,42], while THBS4 influenced cancer stem cell-like properties in PCa via the PI3K/Akt pathway [43]. The gene discussed is SFRP2; the disease is neoplasm.